Page last updated: 2024-11-12

1,2,6,7-tetraoxaspiro(7.11)nonadecane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,6,7-tetraoxaspiro(7.11)nonadecane: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9925476
CHEMBL ID30214
SCHEMBL ID2150801
MeSH IDM0393568

Synonyms (10)

Synonym
1,2,6,7-tetraoxaspiro[7.11]nonadecane
CHEMBL30214
1,2,6,7-tetraoxa-spiro[7.11]nonadecane
SCHEMBL2150801
n-89
1,2,6,7-tetraoxaspiro(7.11)nonadecane
unii-9y3fjl9q6y
n89
229323-98-2
9y3fjl9q6y ,
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID158815Inhibitory concentration against Plasmodium berghei2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
A medicinal chemistry perspective on artemisinin and related endoperoxides.
AID112701in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration2001Journal of medicinal chemistry, Jul-05, Volume: 44, Issue:14
Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes.
AID1873072Antimalarial activity against Plasmodium falciparum Dd2 assessed as inhibition of parasite growth2022European journal of medicinal chemistry, Jul-05, Volume: 237Spiral molecules with antimalarial activities: A review.
AID113178In vivo antimalarial activity to reduce parasitaemia in mice (Mus musculus) infected with Plasmodium berghei by 50% of the control2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
A medicinal chemistry perspective on artemisinin and related endoperoxides.
AID1752692Schistosomicidal-activity against Schistosoma mansoni Puerto-Rican schistosomula incubated for 7 days by trypan blue dye-exclusion test2020RSC medicinal chemistry, Apr-01, Volume: 11, Issue:4
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
AID112702in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on oral administration2001Journal of medicinal chemistry, Jul-05, Volume: 44, Issue:14
Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes.
AID160055In vitro antimalarial activity for Plasmodium falciparum2001Journal of medicinal chemistry, Jul-05, Volume: 44, Issue:14
Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes.
AID72020in vitro cytotoxicity against mouse mammary tumor in cell culture.2001Journal of medicinal chemistry, Jul-05, Volume: 44, Issue:14
Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes.
AID234630Mean of EC50 value for FM3A cells/ mean of EC50 value for Plasmodium falciparum2001Journal of medicinal chemistry, Jul-05, Volume: 44, Issue:14
Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes.
AID112405In vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on oral administration2001Journal of medicinal chemistry, Jul-05, Volume: 44, Issue:14
Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes.
AID159619In vitro antimalarial activity for Plasmodium falciparum2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
A medicinal chemistry perspective on artemisinin and related endoperoxides.
AID112404in vivo antimalarial activity against Plasmodium berghei infected mice (Mus musculus) on intraperitoneal administration2001Journal of medicinal chemistry, Jul-05, Volume: 44, Issue:14
Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes.
AID160042Antimalarial activity in vitro2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Synthesis and notable antimalarial activity of acyclic peroxides, L-(alkyldioxy)-L-(methyldioxy)cyclododecanes.
AID1752693Antischistosomal activity against Schistosoma mansoni Puerto-Rican infected in BALB/c mouse assessed as worm burden reduction at 300 mg/kg, po BID administered for 2 consecutive days by light microscopic method relative to control2020RSC medicinal chemistry, Apr-01, Volume: 11, Issue:4
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
AID1873074Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of parasite growth2022European journal of medicinal chemistry, Jul-05, Volume: 237Spiral molecules with antimalarial activities: A review.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (23.08)29.6817
2010's8 (61.54)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.30 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (23.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (76.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]